Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
17%
OVERLAP
BY WEIGHT
18
# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
34%
ALSO IN SBIO
SBIO
89
HOLDINGS
22%
ALSO IN CANC
SECTOR DRIFT (CANC minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
NUVALENT, INC. CLASS A | 3.3% | 2.8% | 2.8% |
|
CELCUITY INC. | 2.5% | 1.8% | 1.8% |
|
ARCELLX, INC. | 2.5% | 1.6% | 1.6% |
|
CG ONCOLOGY, INC. | 1.3% | 1.3% | 1.3% |
|
IDEAYA BIOSCIENCES, INC. | 2.1% | 1.3% | 1.3% |
CANC Overweight Relative to SBIO
|
REVOLUTION MEDICINES, INC. | 6.3% |
|
ELI LILLY & CO | 5.1% |
|
BRIDGEBIO PHARMA, INC. | 4.4% |
 |
ASTRAZENECA PLC | 4.3% |
 |
NOVARTIS AG | 4.1% |
|
ROCHE HOLDINGS LTD-SPONS ADR | 3.9% |
|
COGENT BIOSCIENCES INC | 3.9% |
 |
GENMAB A/S SPONSORED ADR | 3.8% |
|
BRISTOL-MYERS SQUIBB CO | 3.4% |
|
JOHNSON & JOHNSON | 3.2% |
CANC Underweight Relative to SBIO
|
AVIDITY BIOSCIENCES INC | -4.4% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.0% |
|
RHYTHM PHARMACEUTICALS, INC. | -3.3% |
|
AXSOME THERAPEUTICS, INC. | -3.2% |
|
CYTOKINETICS INC | -3.1% |
 |
MERUS N.V. | -3.0% |
|
KRYSTAL BIOTECH, INC. | -2.9% |
|
PTC THERAPEUTICS INC | -2.4% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.4% |
|
VAXCYTE, INC. | -2.4% |